Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Invested Capital (2016 - 2025)

China Pharma Holdings filings provide 16 years of Invested Capital readings, the most recent being $24.7 million for Q4 2025.

  • On a quarterly basis, Invested Capital rose 177.94% to $24.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $24.7 million, a 177.94% increase, with the full-year FY2025 number at $24.7 million, up 177.94% from a year prior.
  • Invested Capital hit $24.7 million in Q4 2025 for China Pharma Holdings, up from $10.3 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $24.7 million in Q4 2025 to a low of $4.7 million in Q4 2022.
  • Median Invested Capital over the past 5 years was $8.2 million (2024), compared with a mean of $9.0 million.
  • Biggest five-year swings in Invested Capital: plummeted 54.29% in 2022 and later skyrocketed 177.94% in 2025.
  • China Pharma Holdings' Invested Capital stood at $10.3 million in 2021, then crashed by 54.29% to $4.7 million in 2022, then skyrocketed by 79.39% to $8.5 million in 2023, then rose by 4.8% to $8.9 million in 2024, then skyrocketed by 177.94% to $24.7 million in 2025.
  • The last three reported values for Invested Capital were $24.7 million (Q4 2025), $10.3 million (Q3 2025), and $7.9 million (Q2 2025) per Business Quant data.